Clinical Trial Update: Efficacy of TOBI Podhaler vs. Tobramycin Inhalation Solution

View source ↗

Summary

Study comparing TOBI Podhaler (tobramycin inhalation powder) with Tobramycin Inhalation Solution in cystic fibrosis was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• TOBI Podhaler (tobramycin inhalation powder)
• Tobramycin Inhalation Solution (tobramycin inhalation solution)

Snippet

Sponsor: Rush University Medical Center | Conditions: Cystic Fibrosis | Status: TERMINATED | Results posted: 2024-12-06